Redmile Group reported a 14.9% stake in Fate Therapeutics FATE · 17,816,634 sh · amendment

Trade details

Type: 5% stake report
Report: 13D · amendment
Stake: 14.9%
Last report: No earlier report
Shares held: 17,816,634 sh
Class: Common Stock, $0.001 par value per share
Stock: Fate Therapeutics FATE
Holder: Redmile Group
Event date: 24/12/20
Filed: 24/12/26

14.9% stake

Fate Therapeutics trades, last 26 weeks

What else happened in Fate Therapeutics around then

Filed or reported within 30 days of the trade day · 24/11/20~25/01/19

Redmile Group's other 5% stake reports

Redmile Group
5% stakeElectra Therapeutics
5% stake
Electra Therapeutics
ETRA
8.7% stake
5,462,881 sh
8.7% stake
Filed 09/28
Redmile Group
5% stakeNurix Therapeutics
5% stake
Nurix Therapeutics
NRIX
8.1% stake
8,782,256 sh
8.1% stake
Filed 08/14
Redmile Group
5% stakeScholar Rock Holding
5% stake
Scholar Rock Holding
SRRK
3.6% stake
4,311,092 sh
3.6% stake
Filed 08/14
Redmile Group
5% stakeAtara Biotherapeutics
5% stake
Atara Biotherapeutics
ATRA
9.9% stake
950,994 sh
9.9% stake
Filed 07/24
Redmile Group
5% stakeShattuck Labs
5% stake
Shattuck Labs
STTK
9.9% stake
10,019,421 sh
9.9% stake
Filed 07/17